Fact check
“The Food and Drug Administration (FDA) has determined that PRALIDOXIME CHLORIDE (AUTOINJECTOR) solution, 600 milligrams/2 milliliters (300 milligrams/milliliter), was not withdrawn from sale for reasons of safety or effectiveness.”
Reasoning
The claim concerns an FDA regulatory decision about a specific drug product. Without any provided documents, databases, or official FDA statements, there is no basis to verify whether the product was not withdrawn for safety or effectiveness reasons.
On confidence: No evidence was supplied to confirm or refute the FDA's determination regarding PRALIDOXIME CHLORIDE (AUTOINJECTOR) solution.
Important context
Verification would require access to FDA product withdrawal notices, safety communications, or official FDA databases that list withdrawn products and the reasons for withdrawal.
Evidence
No retrievable evidence was found; the verdict rests on the reporting itself and is marked accordingly.
Limitations
The assessment is limited to the absence of supplied evidence. No external sources were consulted, and the claim cannot be confirmed or disproved based solely on the information given.
- Last verified:
- Oct 6, 2026, 4:15 AM CDT
- Pipeline:
- 2.1.0
- Claim type:
- Factual
Where this claim appeared
Determination PRALIDOXIME CHLORIDE (Autoinjector) (Pralidoxime Chloride) Solution, 600 Milligrams/2 Milliliters (300 Milligrams/Milliliter), Was Not Withdrawn From Sale for Reasons of Safety or EffectivenessFederal Register · Drug Administration, Human Services Department, Food, Health